Rice et al. [59] found that both FSTL3 and MDK were upregulated in the serum of treatment-naïve patients with PAH and limited cutaneous SSc (lcSSc) vs. those in lcSSc patients without PAH. The gene discussed is FSTL3; the disease is pulmonary arterial hypertension.